✦ LIBER ✦

Recombinant interferon α-2a in combination with dacarbazine in the treatment of metastatic malignant melanoma: analysis of long-term responding patients

✍ Scribed by Ilan G. Ron; Moshe J. Inbar; Mordechai Gutman; Ofer Merimsky; Samario Chaitchik

Publisher: Springer-Verlag
Year: 1993
Tongue: English
Weight: 987 KB
Volume: 37
Category: Article
ISSN: 0340-7004
DOI: 10.1007/bf01516943

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recombinant leukocyte a interferon (rIFN

Recombinant leukocyte a interferon (rIFN-αA) in the treatment of disseminated malignant melanoma: Analysis of complete and long-term responding patients

✍ Edward T. Creagan; David L. Ahmann; Stephen Frytak; Harry J. Long; Loretta M. It 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 296 KB 👁 1 views

Combined treatment with pegylated interf

Combined treatment with pegylated interferon–α-2a and dacarbazine in patients with advanced metastatic melanoma : A phase 2 study

✍ Axel Hauschild; Reinhard Dummer; Selma Ugurel; Katharina C. Kaehler; Friederike 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB

A phase I-II trial of the combination of

A phase I-II trial of the combination of recombinant leukocyte a interferon and recombinant human interferon-γ in patients with metastatic malignant melanoma

✍ Edward T. Creagan; Charles L. Loprinzi; David L. Ahmann; Daniel J. Schaid 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 325 KB 👁 2 views

A phase II study of combined administrat

A phase II study of combined administration of dacarbazine and carboplatin with home therapy of recombinant interleukin-2 and interferon-α2a in patients with advanced malignant melanoma

✍ Han G. Ron; Yair Mordish; Avi Eisenthal; Yehuda Skornick; Moshe J. Inbar; Samari 📂 Article 📅 1994 🏛 Springer-Verlag 🌐 English ⚖ 584 KB

Recombinant interferon α-2A combined wit

Recombinant interferon α-2A combined with prednisone in metastatic renal-cell carcinoma: Treatment results, serum interferon levels and the development of antibodies

✍ Sophie D. Fosså; Gustav Lehne; Ragnhild Gunderson; Unni Hielmaas; Eduard E. Hold 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 French ⚖ 375 KB 👁 1 views

Five partial responses were seen in 23 patients with metastatic renal-cell carcinoma (MRCC) receiving interferon-a 2a (IFN) + prednisone (P). Four of 24 subsequent patients responded to IFN + P (combined response rate 19%). The median response duration was 8 months (3 to 30 months). The one-year sur

Cisplatin, dacarbazine, and fotemustine

Cisplatin, dacarbazine, and fotemustine plus interferon α in patients with advanced malignant melanoma : A multicenter Phase II study of the Southern Italy Cooperative Oncology Group

✍ Antonio Daponte; Paolo A. Ascierto; Adriano Gravina; Maria Teresa Melucci; Giuse 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views